(VIANEWS) - Old National Bancorp (ONB), OneSpaWorld Holdings Limited (OSW), Brown & Brown (BRO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Old National Bancorp (ONB)
120.6% sales growth and 5.34% return on equity
Old National Bancorp is the bank holding company of Old National Bank. It provides financial services for individual and business customers throughout the United States. Deposit accounts are accepted, with interest bearing checking and noninterest-bearing demands. It also accepts savings and money market deposits. Loans such as residential equity lines of credit and consumer loans. It also offers automated teller machines cards and debit, along with telephone access and online banking. It operated 162 banks centers, mainly in Indiana, Kentucky and Minnesota. Old National Bancorp, which was established in 1834, is located in Evansville (Indiana).
Earnings Per Share
As for profitability, Old National Bancorp has a trailing twelve months EPS of $1.08.
PE Ratio
Old National Bancorp has a trailing twelve months price to earnings ratio of 16.08. Meaning, the purchaser of the share is investing $16.08 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.34%.Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 30, 2022, the estimated forward annual dividend rate is 0.56 and the estimated forward annual dividend yield is 3.17%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 103.3%, now sitting on 1.01B for the twelve trailing months.
Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is 16.3% and 43.2%, respectively.Volume
Today's last reported volume for Old National Bancorp is 580843 which is 63.86% below its average volume of 1607240.
2. OneSpaWorld Holdings Limited (OSW)
60.9% sales growth and 8.04% return on equity
OneSpaWorld Holdings Limited manages health and wellness centres onboard cruise ships as well as at resorts around the world. The company's wellness and health centers provide services such as body, hair, and skin care products, self-service and customized fitness classes and training, pain management and detoxification programs and analysis of the body; weight management products and programs; and medispa services. It also offers its customers access to beauty brands such as Dysport, ELEMIS and KA(c).rastase. It offered beauty, health and fitness services and treatments onboard 159 ships as well as at 53 resorts. It is located in Nassau (Bahamas).
Earnings Per Share
As for profitability, OneSpaWorld Holdings Limited has a trailing twelve months EPS of $0.14.
PE Ratio
OneSpaWorld Holdings Limited has a trailing twelve months price to earnings ratio of 58.57. Meaning, the purchaser of the share is investing $58.57 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.04%.3. Brown & Brown (BRO)
24.2% sales growth and 14.91% return on equity
Brown & Brown, Inc. sells and markets insurance products in the United States, Bermuda, Canada, Cayman islands, Ireland, and Canada. The company operates in four areas: Retail, National Programs and Wholesale Brokerage. It offers builders risk, pharmaceutical and property group, home-owners, retire benefit, cyber, disability, risk mitigation warranty products, directors, officers, management liability and errors, as well as medical stop loss and excess liability. Personal auto, umbrella and general liability are some of its products. It also provides professional liability and related package insurance products for dentistry, legal, eyecare, insurance, financial, physicians, and real estate title professionals, as well as supplementary insurance-related products for weddings, events, medical facilities, and cyber liability; homeowners and personal property policies, residential earthquake, and private passenger automobile and motorcycle coverage; commercial and public entity-related programs; and flood insurance, commercial difference-in-conditions, all-risk commercial property, coastal property programs, lender-placed solutions, sovereign Indian nations, and parcel insurance. It also markets surplus and excess commercial insurance products such as personal lines for homeowners, jewel, commercial property, casualty and commercial vehicle, garage, restaurant and builder's risks, and inland maritime lines. Third-party claims administration, medical utilization management and services in workers' compensation, all-lines liability, Medicare Benefits Advocacy, Social Security Disability, Medicare benefits advocacy and claims adjustment services are available. It was established in Daytona Beach in Florida in 1939.
Earnings Per Share
As for profitability, Brown & Brown has a trailing twelve months EPS of $2.16.
PE Ratio
Brown & Brown has a trailing twelve months price to earnings ratio of 27.54. Meaning, the purchaser of the share is investing $27.54 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.91%.Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 8, 2022, the estimated forward annual dividend rate is 0.41 and the estimated forward annual dividend yield is 0.66%.
Yearly Top and Bottom Value
Brown & Brown's stock is valued at $59.48 at 01:22 EST, way under its 52-week high of $74.00 and way above its 52-week low of $52.91.
4. Liberty Media Corporation (BATRA)
18.2% sales growth and 13.36% return on equity
Through its subsidiary, Braves Holdings, LLC, the Liberty Braves Group owns Atlanta Braves Major League Baseball Club, assets and liabilities as well as mixed-use development projects and ANLBC's stadium. It is located in Englewood Colorado. Liberty Media Corporation is the parent company of Liberty Braves Group.
Earnings Per Share
As for profitability, Liberty Media Corporation has a trailing twelve months EPS of $-1.53.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.36%.Revenue Growth
Year-on-year quarterly revenue growth grew by 43.8%, now sitting on 575M for the twelve trailing months.
Moving Average
Liberty Media Corporation's worth is above its 50-day moving average of $28.71 and above its 200-day moving average of $27.31.Yearly Top and Bottom Value
Liberty Media Corporation's stock is valued at $28.80 at 01:22 EST, way under its 52-week high of $32.69 and way higher than its 52-week low of $24.50.
Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is 8.3% and 41%, respectively.5. Group 1 Automotive (GPI)
15% sales growth and 39.17% return on equity
Group 1 Automotive, Inc., and its affiliates, operate in the auto retail sector. It sells used and new cars and light trucks as well as parts and service insurance. The company also arranges vehicle financing. The company operates in metropolitan areas of 15 US states, 33 in Britain and three in Brazil. The company had 186 dealerships and 242 franchises and 49 collision centres that sold 31 brand-name automobiles as of February 5, 2020. Group 1 Automotive, Inc., was established in Houston, Texas in 1995.
Earnings Per Share
As for profitability, Group 1 Automotive has a trailing twelve months EPS of $19.43.
PE Ratio
Group 1 Automotive has a trailing twelve months price to earnings ratio of 8.46. Meaning, the purchaser of the share is investing $8.46 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 39.17%.6. Casella Waste Systems (CWST)
11.1% sales growth and 11.11% return on equity
Casella Waste Systems, Inc., along with its subsidiaries, is a vertically integrated solid-waste services company in northeastern United States. The company provides resource management services, primarily in areas such as solid waste disposal and transfer, recycling and organics to commercial, residential and municipal customers. It offers a variety of solid waste management services that are non-hazardous, such as collections, disposal, and transfer stations. The company also sells recyclable metals and aluminum as well as plastics and paper. The company also participates in commodity brokerage. It owned or operated 46 solid waste collections, 58 transfer stations and 20 recycling facilities. 8 Subtitle D landfills were also available. 4 landfill gas to-energy plants and one landfill that can accept demolition and construction materials are other facilities. It was established in Rutland in Vermont in 1975.
Earnings Per Share
As for profitability, Casella Waste Systems has a trailing twelve months EPS of $0.95.
PE Ratio
Casella Waste Systems has a trailing twelve months price to earnings ratio of 83.43. Meaning, the purchaser of the share is investing $83.43 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.11%.Moving Average
Casella Waste Systems's worth is below its 50-day moving average of $82.14 and higher than its 200-day moving average of $78.94.Revenue Growth
Year-on-year quarterly revenue growth grew by 31.4%, now sitting on 1B for the twelve trailing months.
Volume
Today's last reported volume for Casella Waste Systems is 348811 which is 76.04% above its average volume of 198143.
7. Vertex Pharmaceuticals (VRTX)
8.9% sales growth and 24.65% return on equity
Vertex Pharmaceuticals Incorporated is a biotechnology firm that develops and markets therapies to treat cystic fibrosis. SYMDEKO/SYMKEVI and ORKAMBI are available to patients suffering from cystic fibrosis. TRIKAFTA is for patients 6 and older with CF who possess at least one F508del mutation. VX-864 is being developed for AAT deficiency treatment and is currently in Phase 2. Clinical trial. VX147 is for treatment of APOL1 mediated focal segmental glomerulosclerosis (or FSGS) and other severe kidney disease. VX-880 is for treatment of Type 1 Diabetes and is in Phase 1/2 clinical trials. VX-548 is a NaV1.8 inhibitor that treats acute, neuropathic and musculoskeletal pain and is in Phase 3. Clinical trial. CTX001 is for treatment of severe SCD/T and TDT and TDT. It sells products to specialty pharmacies, specialty distributors, retail chains and hospitals around the world. Affinia Therapeutics, Inc., Arbor Biotechnologies, Inc., and CRISPR Therapeutics AG are some of its collaborations. ; Kymera Therapeutics, Inc., Mammoth Biosciences, Inc., Moderna, Inc., Obsidian Therapeutics, Inc., Skyhawk Therapeutics, Inc., Ribometrix, Inc., Genomics plc, Merck KGaA, Darmstadt, Germany, as well as X-Chem, Inc. Vertex Pharmacs Incorporated was established in Boston, Massachusetts in 1989.
Earnings Per Share
As for profitability, Vertex Pharmaceuticals has a trailing twelve months EPS of $10.49.
PE Ratio
Vertex Pharmaceuticals has a trailing twelve months price to earnings ratio of 28.31. Meaning, the purchaser of the share is investing $28.31 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.65%.Yearly Top and Bottom Value
Vertex Pharmaceuticals's stock is valued at $297.02 at 01:23 EST, below its 52-week high of $305.95 and way higher than its 52-week low of $177.71.
Sales Growth
Vertex Pharmaceuticals's sales growth is 20% for the ongoing quarter and 8.9% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 7.95B for the twelve trailing months.